Cassava Sciences Inc (SAVA)
22.05
-0.01
(-0.05%)
USD |
NASDAQ |
May 03, 16:00
22.17
+0.12
(+0.54%)
After-Hours: 20:00
Cassava Sciences Market Cap: 953.12M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 953.12M |
| May 02, 2024 | 953.55M |
| May 01, 2024 | 957.01M |
| April 30, 2024 | 957.44M |
| April 29, 2024 | 963.92M |
| April 26, 2024 | 965.65M |
| April 25, 2024 | 939.28M |
| April 24, 2024 | 896.49M |
| April 23, 2024 | 888.28M |
| April 22, 2024 | 886.12M |
| April 19, 2024 | 848.94M |
| April 18, 2024 | 915.94M |
| April 17, 2024 | 919.40M |
| April 16, 2024 | 909.03M |
| April 15, 2024 | 864.94M |
| April 12, 2024 | 983.37M |
| April 11, 2024 | 1.129B |
| April 10, 2024 | 1.059B |
| April 09, 2024 | 1.098B |
| April 08, 2024 | 1.019B |
| April 05, 2024 | 921.13M |
| April 04, 2024 | 885.25M |
| April 03, 2024 | 889.57M |
| April 02, 2024 | 851.97M |
| April 01, 2024 | 877.04M |
| Date | Value |
|---|---|
| March 28, 2024 | 877.04M |
| March 27, 2024 | 882.66M |
| March 26, 2024 | 851.97M |
| March 25, 2024 | 851.54M |
| March 22, 2024 | 856.29M |
| March 21, 2024 | 915.51M |
| March 20, 2024 | 949.66M |
| March 19, 2024 | 950.52M |
| March 18, 2024 | 919.83M |
| March 15, 2024 | 920.26M |
| March 14, 2024 | 894.33M |
| March 13, 2024 | 892.60M |
| March 12, 2024 | 899.52M |
| March 11, 2024 | 797.07M |
| March 08, 2024 | 811.77M |
| March 07, 2024 | 832.09M |
| March 06, 2024 | 857.59M |
| March 05, 2024 | 925.45M |
| March 04, 2024 | 973.00M |
| March 01, 2024 | 994.18M |
| February 29, 2024 | 993.32M |
| February 28, 2024 | 991.15M |
| February 27, 2024 | 994.18M |
| February 26, 2024 | 947.50M |
| February 23, 2024 | 926.26M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
17.56M
Minimum
May 20 2019
5.414B
Maximum
Jul 28 2021
1.012B
Average
945.11M
Median
Jul 18 2022
Market Cap Benchmarks
| Amylyx Pharmaceuticals Inc | 137.60M |
| Clearside Biomedical Inc | 97.88M |
| Lantern Pharma Inc | 66.06M |
| NovaBay Pharmaceuticals Inc | 2.856M |
| Palatin Technologies Inc | 34.05M |
Market Cap Related Metrics
| PS Ratio | 22.49 |
| Price to Book Value | 6.933 |
| Price | 22.05 |
| Earnings Yield | -10.52% |
| Operating PE Ratio | 29.48 |
| Normalized PE Ratio | 4.632 |